Case number 1:24-cv-00327
American Regent, Inc. v. Apotex, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 19, 2024 | 10 | ORAL ORDER: Because the plaintiff has decided to voluntarily dismiss its claims without prejudice (D.I. 9 ), I DIRECT the Clerk to close this case. ***Civil Case Terminated. Ordered by Judge Stephanos Bibas on 07/19/2024. (vfm) (Entered: 07/19/2024) (0) |
| Jul 19, 2024 | 11 | FINAL Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 11,786,548. (vfm) (Entered: 07/19/2024) (1) |
| Jul 18, 2024 | 9 | NOTICE of Voluntary Dismissal by American Regent, Inc. as to Without Prejudice (Viceconte, Christopher) (Entered: 07/18/2024) (2) |
| Apr 11, 2024 | 8 | ORDER: DESIGNATION OF CIRCUIT JUDGE TO HOLD A DISTRICT COURT WITHIN THE CIRCUIT, designating and assigning the Honorable Stephanos Bibas of the United States Court of Appeals for the Third Circuit. Signed by Judge Michael A Chagares, Chief Judge of the United States Court of Appeals for the Third Circuit on 4/11/2024. (rjb) (Entered: 04/11/2024) (1) |
| Apr 11, 2024 | N/A | Case Reassigned to Judge Stephanos Bibas of the United States Court of Appeals for the Third Circuit. Please include the initials of the Judge (SB) after the case number on all documents filed. (rjb) (Entered: 04/11/2024) (0) |
| Mar 20, 2024 | N/A | Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) (Entered: 03/20/2024) (0) |
| Mar 15, 2024 | N/A | CORRECTING ENTRY: Counsel is advised to refile their AO 120 Patent form with the proper event code in order for the Patent and and Trademark Office to be notified. Previous entry has been removed. (smg) (Entered: 03/15/2024) (0) |
| Mar 15, 2024 | 7 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 11,786,548 "Corrected". (Viceconte, Christopher) (Entered: 03/15/2024) (1) |
| Mar 13, 2024 | 1 | COMPLAINT filed against Apotex Corp., Apotex, Inc. ( Filing fee $ 405, receipt number ADEDC-4360223.) - filed by American Regent, Inc.. (Attachments: # 1 Exhibit 1, # 2 Civil Cover Sheet)(mpb) (Entered: 03/13/2024) (0) |
| Mar 13, 2024 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 03/13/2024) (3) |
| Mar 13, 2024 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/31/2024. Date of Expiration of Patent: 7/1/2041.Thirty Month Stay Deadline: 7/31/2026. (mpb) (Entered: 03/13/2024) (1) |
| Mar 13, 2024 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 11,786,548. (mpb) (Entered: 03/13/2024) (1) |
| Mar 13, 2024 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Daiichi Sankyo Company, Limited, Corporate Parent Daiichi Sankyo, Inc., Corporate Parent Daiichi Sankyo U.S. Holdings, Inc. for American Regent, Inc. filed by American Regent, Inc.. (mpb) (Entered: 03/13/2024) (2) |
| Mar 13, 2024 | 6 | Summons Issued as to Apotex Corp. on 3/13/2024; Apotex, Inc. on 3/13/2024. (Attachments: # 1 Summons Issued)(mpb) (Entered: 03/13/2024) (0) |
